Disclosure of Change of Corporate Office Pursuant to Regualtion 30 of the SEBI (LODR) Regulations 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed BSE that its Board of Directors, at a meeting held on 2 February 2026, approved the removal of its Corporate Office located at Vikram Tower, Rajendra Place, New Delhi-110060. Going forward, the company's Registered Office at Vardan Tower, Navrangpura, Ahmedabad-380009 will also serve as the Corporate Office. All official communications and business activities will now be handled from the Ahmedabad address. The company stated the decision was made for operational efficiency and better administrative management. The board meeting ran from 3:50 PM to 4:15 PM. The disclosure was signed by Rajender Parsad, Additional Director.
This is a routine administrative restructuring with no direct impact on shareholders' financial interests. Consolidating operations to the Ahmedabad Registered Office may slightly reduce overhead costs, but is unlikely to materially affect the stock price or business performance.